CIK 0001726445 · Non-accelerated filer<br>Smaller reporting company
Seer, Inc.
Sign in to watch- Ticker
- SEER
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821153150
- Phone
- 650-453-0000
- Business address
- 3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY, CA, 94065
- Former names
- Seer Biosciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $14,809
- in 1 filing
Net −$14,809. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 40 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-04 | Farokhzad Omid CEO and Chair | Returned to the company · Employee Stock Option (right to buy) | −87,000 | 0 | ||
| 2024-10-04 | Farokhzad Omid CEO and Chair | Grant or award · Employee Stock Option (right to buy) | +87,000 | 87,000 | ||
| 2024-10-04 | Farokhzad Omid CEO and Chair | Returned to the company · Employee Stock Option (right to buy) | −650,000 | 0 | ||
| 2024-10-04 | Farokhzad Omid CEO and Chair | Grant or award · Employee Stock Option (right to buy) | +650,000 | 650,000 | ||
| 2024-08-13 | Roelofs Nicolas H PHD Director | Grant or award | +46,886 | 57,913 | ||
| 2024-08-13 | Roelofs Nicolas H PHD Director | Grant or award · Stock Option (right to buy) | +69,470 | 69,470 | ||
| 2024-06-14 | Nishar Dipchand Director | Sale 10b5-1 | −12,109 | $1.78 | $22K | 79,457 |
| 2024-06-12 | Nishar Dipchand Director | Grant or award | +58,178 | 91,566 | ||
| 2024-06-12 | MCGUIRE TERRANCE Director | Grant or award | +58,178 | 91,566 | ||
| 2024-06-12 | LANGER ROBERT Director | Grant or award | +58,178 | 784,025 | ||
| 2024-06-12 | Haurwitz Rachel E. Director | Grant or award | +58,178 | 87,615 | ||
| 2024-06-12 | Hallal David Director | Grant or award | +58,178 | 355,128 | ||
| 2024-06-12 | Gulyani Meeta Director | Grant or award | +58,178 | 87,043 | ||
| 2024-03-07 | Farokhzad Omid CEO AND CHAIR | Sale | −52,857 | $2.03 | $107K | 1,436,285 |
| 2024-02-22 | Kogan Elona CHIEF LEGAL OFFICER | Sale | −12,684 | $1.58 | $20K | 273,142 |
| 2024-02-22 | Horn David R. PRESIDENT & CFO | Sale | −12,684 | $1.58 | $20K | 480,511 |
| 2024-02-06 | Kogan Elona CHIEF LEGAL OFFICER | Grant or award | +123,153 | 285,826 | ||
| 2024-02-06 | Kogan Elona CHIEF LEGAL OFFICER | Grant or award · Employee Stock Option (right to buy) | +79,729 | 79,729 | ||
| 2024-02-06 | Kogan Elona CHIEF LEGAL OFFICER | Grant or award · Employee Stock Option (right to buy) | +140,000 | 140,000 | ||
| 2024-02-06 | Horn David R. PRESIDENT & CFO | Grant or award | +165,038 | 493,195 |
Page 5 of 10 · 196 trades